share_log

Insider Purchase: Director at $IPWR (IPWR) Buys 3,000 Shares

Quiver Quantitative ·  Nov 21 06:30

Laban E Lesster, a director at $IPWR ($IPWR), bought 3,000 shares of the company on 11-19-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 22.6%. Following this trade, they now own 16,252 shares of $IPWR stock.

$IPWR Insider Trading Activity

$IPWR insiders have traded $IPWR stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

Here's a breakdown of recent trading of $IPWR stock by insiders over the last 6 months:

  • LABAN E LESSTER purchased 3,000 shares.
  • DANIEL BRDAR (President and CEO) purchased 4,500 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$IPWR Hedge Fund Activity

We have seen 10 institutional investors add shares of $IPWR stock to their portfolio, and 12 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • AWM INVESTMENT COMPANY, INC. added 439,180 shares (+270.5%) to their portfolio in Q3 2024
  • TIMELO INVESTMENT MANAGEMENT INC. removed 100,000 shares (-100.0%) from their portfolio in Q2 2024
  • BAIRD FINANCIAL GROUP, INC. added 26,572 shares (+12.7%) to their portfolio in Q3 2024
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP added 14,442 shares (+inf%) to their portfolio in Q3 2024
  • CITADEL ADVISORS LLC removed 11,037 shares (-100.0%) from their portfolio in Q2 2024
  • VIRTU FINANCIAL LLC removed 10,107 shares (-100.0%) from their portfolio in Q2 2024
  • GEODE CAPITAL MANAGEMENT, LLC added 9,075 shares (+13.2%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment